Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

January 12, 2022

Ask the Doctor Question: I had four successive adverse “anaphylactoid” reactions to rituximab, (as part of a Fludarabine-Rituximab protocol here in Vancouver, Canada) before that treatment was abandoned. Am I at greater than usual risk of anaphylactoid reaction to the post-exposure antibody treatment currently available? Answer: If you have had
Ask the Doctor Question: During CLL Society’s COVID Virtual Community meeting on 9/24, did I understand Dr. Lamanna to say she is routinely giving her CLL patients prophylactic pre-exposure monoclonal antibody infusions? If so, can I get this from my oncologist? Answer: Dr. Lamanna has responded that “currently, I am only